- Provides effective flea control within 8 hours after treatment. 1,2
- Continues to effectively kill newly arriving fleas within 8 hours, throughout the entire 3-month treatment interval. 1,2
- Reduces the incidence of flea allergy dermatitis by controlling adult fleas.
- Controls brown dog ticks for 8 weeks.
- Highly palatable tasty oral chew format.
- Can be used in puppies from 8 weeks of age and in breeding, pregnant and lactating dogs.
- Rapid and consistent tick and flea efficacy. 1,2,3
- Bravecto’s extended protection periods 3 mean clients have fewer treatments to remember each year, therefore less to forget.
- Bravecto gives immediate and persistent protection lasting the entire length of the flea lifecycle.
- No mess to administer, won’t wash or rub off.
- Peace of mind for your clients knowing their pet is protected.
- Simple dosing for increased convenience.
- MSD data on file.
- Taenzler J, Wengenmayer C et al. Onset of activity of fluralaner (Bravecto™) against Ctenocephalides felis on dogs. Parasites & Vectors (2014) 7:567.
- 3 months protection against fleas, 4 months protection against paralysis ticks and 8 weeks protection against brown dog ticks. Refer to label for foll claim details.
Our vision at MSD Animal Health is The Science of Healthier Animals, and Bravecto is a remarkable result of that vision.
This tick and flea treatment for dogs achieves the combination of highly potent insecticidal efficacy and persistent activity with a strong safety profile.
We are very proud to bring to you the following peer-reviewed publications, recognizing that these papers present just a fraction of the tremendous effort that went into developing and obtaining regulatory approval for Bravecto (fluralaner).
Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs
Efficacy of fluralaner flavored chews (Bravecto®) administered to dogs against the adult cat flea, Ctenocephalides felis and egg production
Fluralaner, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment.
A small-scale open-label study of the treatment of canine flea allergy dermatitis with fluralaner.
Open field study on the efficacy of oral fluralaner for long-term control of flea allergy dermatitis in client-owned dogs in Ile-de-France region
The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs.
Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™).
Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs.
A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto™) treated vs. untreated dogs using the parameters tick weight and coxal index.
Fluralaner activity against life stages of ticks using Rhipicephalus sanguineus and Ornithodoros moubata IN in vitro contact and feeding assays.
A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations.
A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against FrontlineTM (fipronil) in flea- and tick-infested dogs.
A randomized controlled trial of the efficacy of orally administered fluralaner (Bravecto™) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs.
Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime – praziquantel.
Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin).
Safety of fluralaner chewable tablets (Bravecto™), a novel systemic antiparasitic drug, in dogs after oral administration.
Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration.
Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration.
The effect of food on the pharmacokinetics of oral fluralaner in dogs.
Veterinary Nurse Training
An interactive online training module designed to assist vet nurses in building their knowledge of ectoparasites and the features and benefits of Bravecto.